Clinical Trial Update: Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) [NA]

View source ↗

Summary

This clinical trial update indicates that Signos Inc's SIGNOS-CGM-EMPOWER-201-2022 study on weight loss and metabolic syndrome is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Signos Inc | Conditions: Weight Loss, Metabolic Syndrome | NA | Status: ACTIVE_NOT_RECRUITING